Cargando…

Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice

Detalles Bibliográficos
Autores principales:	Werner, Franziska, Kojonazarov, Baktybek, Gaßner, Birgit, Abeßer, Marco, Schuh, Kai, Völker, Katharina, Baba, Hideo A., Dahal, Bhola K., Schermuly, Ralph T., Kuhn, Michaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885509/ https://www.ncbi.nlm.nih.gov/pubmed/35229176 http://dx.doi.org/10.1007/s00395-022-00916-9

Ejemplares similares

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Genes involved in pulmonary hypertension of mice with endothelial-specific ablation of guanylyl cyclase A
por: Werner, Franziska, et al.
Publicado: (2013)

C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction
por: Roloff, Konstanze, et al.
Publicado: (2015)

Role of atrial natriuretic peptide (ANP) in the regulation of insulin secretion and vitality of pancreatic ß cells
por: Tauscher, Sabine, et al.
Publicado: (2015)

C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
por: Michel, Konstanze, et al.
Publicado: (2020)

C-type natriuretic peptide prevents activation of perivascular mast cells and inflammation in the postischemic microvasculature
por: Chen, Wen, et al.
Publicado: (2015)

A novel noninvasive method for estimating right ventricular systolic pressure in rodents with pulmonary artery banding
por: Kojonazarov, Baktybek, et al.
Publicado: (2023)

A splice variant of the guanylyl cyclase-A receptor interferes with atrial natriuretic peptide (ANP) signaling
por: Hartmann, Michael, et al.
Publicado: (2009)

Ablation of C-type natriuretic peptide/cGMP signaling in fibroblasts exacerbates adverse cardiac remodeling in mice
por: Werner, Franziska, et al.
Publicado: (2023)

β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice
por: Tauscher, Sabine, et al.
Publicado: (2018)

Atrial natriuretic peptide increases the albumin permeability of mouse skeletal muscle microcirculation by the caveolae-mediated transcellular pathway
por: Chen, Wen, et al.
Publicado: (2011)

Effects of riociguat in severe experimental pulmonary hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2011)

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats
por: Lang, Michaela, et al.
Publicado: (2011)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway
por: Chen, Wen, et al.
Publicado: (2012)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

Homologous desensitization of guanylyl cyclase A, the receptor for atrial natriuretic peptide, is associated with a complex phosphorylation pattern
por: Schröter, Juliane, et al.
Publicado: (2010)

Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis
por: Boehm, Mario, et al.
Publicado: (2022)

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
por: Veeroju, Swathi, et al.
Publicado: (2021)

The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
por: Lang, Michaela, et al.
Publicado: (2012)

Natriuretic peptides, via GC-A/cGMP, moderate hypoxia-induced VEGF release from astrocytes and thereby pathological neovascularization in the retina
por: Spiranec, Katarina, et al.
Publicado: (2015)

Dual actions of ANP on endothelial permeability
por: Chen, Wen, et al.
Publicado: (2013)

Heart Rate Reduction by Ivabradine: Slowly but Surely?
por: Kojonazarov, Baktybek
Publicado: (2020)

The good and the ugly: ANP antagonizes the deleterious effects of aldosterone in hypertensive cardiac remodeling
por: Nakagawa, Hitoshi, et al.
Publicado: (2013)

Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4)
por: Lu, Shun, et al.
Publicado: (2017)

Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling
por: Kojonazarov, Baktybek, et al.
Publicado: (2013)

Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2
por: Klaiber, Michael, et al.
Publicado: (2010)

IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
por: Biswas, Siladitta, et al.
Publicado: (2020)

Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding
por: Rai, Nabham, et al.
Publicado: (2018)

Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
por: Rai, Nabham, et al.
Publicado: (2018)

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension
por: Rai, Nabham, et al.
Publicado: (2022)

Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
por: Amirjanians, Matthieu, et al.
Publicado: (2017)

Effect of p53 activation on experimental right ventricular hypertrophy
por: Veeroju, Swathi, et al.
Publicado: (2020)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018)

Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice
por: Sydykov, Akylbek, et al.
Publicado: (2020)

Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2022)

Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
por: Chappell, Daniel, et al.
Publicado: (2014)

The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
por: Dahal, Bhola K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_80mhkehomk86otqgtvmuni6arg